Replies to post #44226 on Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

I have a couple of upcoming dates on my calendar to watch:

May 25, 2022 - DSMB meeting related to the NIH clinical trial (will they unblind and take a peak at efficacy?)
For the ongoing ZYESAMI® NIH Phase III ACTIV-3b Trial, the next DSMB meeting is scheduled for May 25, 2022, instead of an originally planned meeting in April.

The NIH ACTIV-3b Trial leadership indicated to NRx Pharmaceuticals that this new timing would allow the vast majority of patients enrolled to date to have reached the 90-day observation period endpoint.

June 5, 2022 PDUFA date for ACER-001